Trevena Attends National Institutes of Health Meeting to Discuss Development of Novel, Improved Pain Medications KING OF PRUSSIA, Pa., June 20, 2017 (GLOBE NEWSWIRE) -- Trevena, Inc. (NASDAQ:TRVN) today announced its recent participation in the “Cutting Edge Science Meeting Series to End the Opioid Crisis:...